Though mobile devices and Apple Silicon have seen ARM-64 explode across the world, there’s still decent odds you’re reading ...
1d
How Investors Are Reacting To Tempus AI (TEM) Earnings Surge and New Lymphoma Research Partnership
Tempus AI recently reported third quarter 2025 earnings, highlighted by revenue of US$334.21 million, up from US$180.93 million a year ago, and an improved net loss, while also announcing a new ...
Researchers have created a prediction method that comes startlingly close to real-world results. It works by aiming for ...
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) Kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback